Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer-Reference-Cited by-同舟云学术

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

Published:2009-12 Issue:12 Volume:20 Page:1953-1958
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Liedtke C.,Broglio K.,Moulder S.,Hsu L.,Kau S.-W.,Symmans W.F.,Albarracin C.,Meric-Bernstam F.,Woodward W.,Theriault R.L.,Kiesel L.,Hortobagyi G.N.,Pusztai L.,Gonzalez-Angulo A.M.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/12/1953/13780809/mdp263.pdf

Reference23 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci U S A,2001

3. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;Liedtke;J Clin Oncol,2008

4. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes;Carey;Clin Cancer Res,2007

5. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer;Harris;J Clin Oncol,2007

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen-Receptor Loss and ESR1 Mutation in Estrogen-Receptor-Positive Metastatic Breast Cancer and the Effect on Overall Survival;Cancers;2024-08-30

2. Receptor Discordance in Metastatic Breast Cancer; a review of clinical and genetic subtype alterations from primary to metastatic disease;Breast Cancer Research and Treatment;2024-08-01

3. Biomarker conversion from primary breast cancer to synchronous axillary lymph node metastasis and neoadjuvant therapy response: a single-center analysis;Journal of Cancer Research and Clinical Oncology;2024-06-08

4. Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival;Breast Cancer Research and Treatment;2024-05-23

5. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors;PeerJ;2024-05-15